Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial.
Neuro Oncol. 2023 Jan 5;25(1):157-166. doi: 10.1093/neuonc/noac144.
Neuro Oncol. 2023.
PMID: 35639825
Free PMC article.
Clinical Trial.
Clinical Implications of Extracellular HMGA1 in Breast Cancer.
Méndez O, Pérez J, Soberino J, Racca F, Cortés J, Villanueva J.
Méndez O, et al. Among authors: racca f.
Int J Mol Sci. 2019 Nov 26;20(23):5950. doi: 10.3390/ijms20235950.
Int J Mol Sci. 2019.
PMID: 31779212
Free PMC article.
Review.
Item in Clipboard
Atezolizumab in the treatment of metastatic triple-negative breast cancer.
Pérez-García J, Soberino J, Racca F, Gion M, Stradella A, Cortés J.
Pérez-García J, et al. Among authors: racca f.
Expert Opin Biol Ther. 2020 Sep;20(9):981-989. doi: 10.1080/14712598.2020.1769063. Epub 2020 May 25.
Expert Opin Biol Ther. 2020.
PMID: 32450725
Review.
Item in Clipboard
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Prat A, Paz-Ares L, Juan M, Felip E, Garralda E, González B, Arance A, Martín-Liberal J, Gavilá J, López-González A, Cejalvo JM, Izarzugaza Y, Amillano K, Corbacho JG, Saura C, Racca F, Hierro C, Sanfeliu E, Gonzalez X, Canes J, Villacampa G, Salvador F, Pascual T, Mesía R, Cervantes A, Tabernero J.
Prat A, et al. Among authors: racca f.
Future Oncol. 2022 Oct 6. doi: 10.2217/fon-2022-0660. Online ahead of print.
Future Oncol. 2022.
PMID: 36200668
Review.
Item in Clipboard
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors.
Hanna GJ, Stathis A, Lopez-Miranda E, Racca F, Quon D, Leyvraz S, Hess D, Keam B, Rodon J, Ahn MJ, Kim HR, Schneeweiss A, Ribera JM, DeAngelo D, Perez Garcia JM, Cortes J, Schönborn-Kellenberger O, Weber D, Pisa P, Bauer M, Beni L, Bobadilla M, Lehal R, Vigolo M, Vogl FD, Garralda E.
Hanna GJ, et al. Among authors: racca f.
Cancer Res Commun. 2023 Sep 14;3(9):1853-1861. doi: 10.1158/2767-9764.CRC-23-0333.
Cancer Res Commun. 2023.
PMID: 37712875
Free PMC article.
Clinical Trial.
Item in Clipboard
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.
Morales-Barrera R, Suárez C, de Castro AM, Racca F, Valverde C, Maldonado X, Bastaros JM, Morote J, Carles J.
Morales-Barrera R, et al. Among authors: racca f.
Cancer Treat Rev. 2016 Nov;50:208-216. doi: 10.1016/j.ctrv.2016.09.018. Epub 2016 Oct 1.
Cancer Treat Rev. 2016.
PMID: 27743530
Review.
Item in Clipboard
Concurrent palliative external radiotherapy with sorafenib or doxorubicin for bulky differentiated thyroid carcinoma: A case report.
Cortés-Mateus KS, Holub K, Racca F, Grau JJ, Capdevila J.
Cortés-Mateus KS, et al. Among authors: racca f.
Oncol Lett. 2018 Sep;16(3):4085-4089. doi: 10.3892/ol.2018.9069. Epub 2018 Jul 4.
Oncol Lett. 2018.
PMID: 30128032
Free PMC article.
Item in Clipboard
Cite
Cite